Loading resource…

National Institute for Health and Care Excellence (NICE)
The guidance outlines the recommendations made by the National Institute for Health and Care Excellence (NICE) regarding the use of roxadustat, a medication for managing anaemia associated with chronic kidney disease. It emphasizes the importance of considering individual patient needs and the responsibilities of healthcare professionals in applying these recommendations. The document also discusses the economic modeling and cost-effectiveness of roxadustat in clinical practice.
No account needed